메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
김상현 (서울대학교)
저널정보
대한의사협회 대한의사협회지 대한의사협회지 제60권 제11호
발행연도
2017.1
수록면
901 - 911 (11page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Statins are the first choice of pharmacological treatment for dyslipidemia to prevent atherosclerotic cardiovascular disease. Ample evidence demonstrates the benefits and safety of statin, including the lipid-lowering efficacy and the ability to improve clinical prognosis. High-intensity statin therapy is especially recommended in high-risk patients and those with cardiovascular disease. However, clinical trials, meta-analyses, and retrospective analyses have shown 9% to 13% increase in the risk of new-onset diabetes with statin therapy. The risk of new-onset diabetes with statin increased with higher statin doses, and the mechanisms are not yet fully understood. Mendelian randomization studies have suggested that new-onset diabetes with statin may be related to the activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase or low density lipoprotein receptor. Patients with familial hypercholesterolemia did not show an increased risk of new-onset diabetes with statin compared to their unaffected relatives. Moreover, some studies have shown that different kinds of statins impaired pancreatic beta-cell function. Recently, genetic analysis studies have shown probable associations between changes in several proteins involving lipid metabolism and the increased risk of new-onset diabetes. Statin therapy should be emphasized to prevent and treat atherosclerotic cardiovascular disease on the basis of individual cardiovascular risk and clinical characteristics, especially in high-risk patients, such as those with diabetes. It is important to combine statin therapy with patient education and lifestyle modifications, including diet control, exercise, and weight changes, to manage dyslipidemia and minimize the risk of new-onset diabetes. Statin therapy should be considered more important and the risk of new-onset diabetes with statin should not be overemphasized.

목차

등록된 정보가 없습니다.

참고문헌 (40)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0